Application of crosslinked polyethylenimine as oncoprotein antigen vaccine vector
A polyethyleneimine, tumor protein technology, applied in the direction of antitumor drugs, antibody medical ingredients, medical preparations with non-active ingredients, etc., can solve problems such as application limitations, PEI cannot be degraded, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] In this example, the degradable PEI containing imine bonds synthesized by small molecular weight PEI and DTBP was used as the antigen carrier material. For the synthesis method, refer to the literature (M.A.Gosselin, W.Guo, and R.J.Lee, "Efficient gene transfer using reversibly cross- linked low molecular weight polyethyleneimine," Bioconjugate Chemistry, vol. 12, no. 6, pp. 989–994, 2001.).
[0039] The specific steps for the preparation of the composite nanoparticles of the present embodiment are as follows:
[0040] 1. Cross-link PEI and DTBP to form a degradable PEI polymer with a molecular weight of 1000Da containing disulfide bonds (hereinafter referred to as PEI-DS) dissolved in ddH 2 In O, make a 0.2mg / mL stock solution; make OVA a 5mg / mL stock solution with 10mM HEPES buffer at pH 7.4;
[0041] 2. Add the same volume of 5 mg / mL OVA solution to 0.2 mg / mL PEI-DS solution under vortex conditions, and mix them evenly to obtain composite nanoparticles.
[0042] Th...
Embodiment 2
[0058] The synthesis method used in this example is the same as in Example 1, except that the weight average molecular weight of the small molecular weight PEI used in this example is 1000Da, and the weight average molecular weight of the synthesized polymer polymer is 50000Da.
[0059] PEI-DS / OVA composite nanoparticles were prepared according to the same method as in Example 1, and the measured particle diameter was 280nm, and the potential was -16mv. Cytotoxicity assays such as Figure 7 As shown, the antigen cross-presentation experiment was performed as Figure 8 shown. It can be seen from the figure that the antigen cross-presentation effect of the prepared complex nanoparticles is 3 times that of PEI25KDa, and the proportion of living cells is increased by 51%.
[0060] The antitumor effect of composite nanoparticles such as Figure 9 with Figure 10 As shown, the smaller the tumor after 7 days, the better the effect, and the higher the mouse survival rate, the bett...
Embodiment 3
[0062] The synthesis method used in this example is the same as Example 1, except that the weight average molecular weight of the small molecular weight PEI used in this example is 2000Da, and the weight average molecular weight of the synthesized polymer polymer is 100000Da.
[0063] PEI-DS / OVA composite nanoparticles were prepared according to the same method as in Example 1, and the measured particle diameter was 280nm, and the potential was -16mv. Cytotoxicity assays such as Figure 11 As shown, the antigen cross-presentation experiment was performed as Figure 12 shown. It can be seen from the figure that the antigen cross-presentation effect of the prepared complex nanoparticles is 3.7 times higher than that of PEI25KDa, and the corresponding ratio of living cells is increased by 54%.
[0064] The antitumor effect of composite nanoparticles such as Figure 13 with Figure 14 As shown, the smaller the tumor after 7 days, the better the effect, and the higher the mouse...
PUM
Property | Measurement | Unit |
---|---|---|
Weight average molecular weight | aaaaa | aaaaa |
Weight average molecular weight | aaaaa | aaaaa |
Weight average molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com